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Abstract
Introduction: Angiographic flow in an epicardial artery does not define perfusion
at a microvascular level in patients with acute myocardial infarction (AMI). The
aim of the study was assessing microvascular reperfusion by myocardial contrast
echocardiography (MCE) and left ventricular (LV) functional recovery by
echocardiographic methods in patients treated with primary PTCA.
Material and methods: 100 consecutive patients with first ST-elevation AMI with
single vessel disease treated successfully with primary PCI were enrolled.
Regional contrast score index (RCSI), ejection fraction (EF), wall motion score
index (WMSI), and end-systolic and end-diastolic volume (ESV, EDV) were
evaluated during hospitalization and at 6-month follow-up. The patients were
divided into 2 groups according to the absence (Group 1) or presence (Group 2)
of perfusion defects on MCE.
Results: Group 1 had lower WMSI (p = 0.0009), higher EF than Group 2 (44.7
and 55.9% respectively, p = 0.000067), and lower ESV (66.0 and 52.6 ml
respectively, p = 0.003185). In Group 1 LVEF increased significantly on 6-month
follow-up (p = 0.026), while in Group 2 it decreased (p = 0.0175). Both EDV and
ESV were significantly lower in Group 1 (p = 0.0106 and p = 0.002882,
respectively). There was a correlation between the presence of perfusion defects
in the initial contrast echo and unfavourable change in ejection fraction during
the follow-up (ANOVA for repeated measures, F[1.91] = 5.85, p = 0.0175). The
combined clinical end-point (death and reinfarction) was significantly lower in
patients without perfusion defect (p = 0.039).
Conclusions: Myocardial contrast echocardiography results correlated with clinical
outcome and recovery of systolic left ventricular function at 6-month follow-up.
Key words: myocardial perfusion, contrast echocardiography, left ventricular function,
survival after myocardial infarction.
Introduction
Angiographic flow in an epicardial artery does not accurately define
perfusion at a microvascular level [1]. A lack of myocardial reperfusion in
spite of restored flow, the “no-reflow” phenomenon, was initially revealed
by myocardial contrast echocardiography and confirmed by other imaging
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techniques such as positron emission tomography
[2, 3]. In AMI a lack of myocardial perfusion despite
recanalization of the infarct-related artery (IRA) is
associated with an increased rate of left ventricular
dysfunction, complications and impaired survival
[4-7].
Therefore there is a need to apply techniques
assessing flow at a tissue level at bedside.
Myocardial contrast echocardiography (MCE) in AMI
provides information regarding the adequacy of
myocardial tissue perfusion as well as the spatial
extent of microvascular obstruction. 
There are limited data showing perfusion
assessed by contrast echocardiography with
echocardiographic contractility parameters in
patients with first AMI successfully treated with
angioplasty on follow-up.
The purpose of this study was to assess
microvascular reperfusion by MCE, LV functional
recovery by echocardiographic methods and clinical
outcome in patients with first AMI successfully
treated with primary PTCA. 
Material and methods
Study population
Hundred consecutive patients with a first AMI
admitted within 12 h of onset of chest pain, and
treated with primary PCI, were enrolled in our study.
Only patients with single vessel disease were
included in the present study. Exclusion criteria
were: 1) cardiogenic shock at the time of MCE, 
2) unsuccessful angioplasty, TIMI flow post PCI < 3
and residual lesion > 30%, 3) clinical history of
congestive heart failure or valve disease, 
4) pregnancy or breastfeeding, 5) life-threatening
condition other than AMI, 6) inadequate thoracic
window for echocardiography. No upper age limit
was defined.
The study complies with the declaration of
Helsinki. The study protocol was approved by the
local ethics committee and informed consent was
obtained from all subjects participating in the study.
Clinical characteristics are shown in Table I.
Almost all patients received aspirin, β-blockers,
ACE inhibitors, and statins from the first day of
treatment. In case of stent implantation (90% of
patients) clopidogrel was administered. 
The patients were divided into 2 groups
according to absence (Group 1) or presence (Group 2)
of perfusion disturbances on MCE. 
Echocardiographic analysis
All studies were performed using the Philips
Ultrasound System Sonos 5500 equipped for
harmonic imaging and 3.6 MHz transducer.
Instrument setting for myocardial contrast
echocardiography was optimized in order to have
maximum sensitivity and ideal conditions for visual
myocardial contrast detection. The recommended
dynamic range was in the medium or mid range
(45-55 dB); focal zone depth was set at
approximately 2/3 of the image; gain was adjusted
so that myocardial tissue speckle details could be
seen on baseline images (this resulted in
homogeneous grey backscatter throughout the
entire wall of the left ventricle). Mechanical index
was set between 0.3 and 0.9. Thereafter, all settings
were kept constant during the acquisition of
images. The dysfunctional area was visualized using
harmonic imaging in either the 4- or 2-chamber
view. ECG triggering was done in late end-systole
at every third heart beat with image acquisition at
the T-wave of the ECG signal. 
Evaluated  Patients without  perfusion Patients with perfusion Value of p
parameters defect n = 53 defect n = 47
Mean age [years] 58.3 (SD ± 11.33) 60.8 (SD ±12.82) 0.31
Male [%] 56.9  58.2  0.68
Hypertension [%] 64.2 65.2  0.91
Diabetes mellitus [%] 37.7 26.1 0.22 
Dyslipidaemia [%] 60.4 63.1 0.79
Smoking [%] 17.3 21.7 0.58
CK-MB (max. value IU/l) 197.8 (SD ±129.2) 244.2 (SD ±161.9) 0.13
Patients with anterior MI [%] 24.5 63.6 0.000014
Time from pain onset to balloon 270.7 (SD ±171.4) 288.6 (SD ±223.5) 0.68
TIMI before PCI 0.8 (SD ±1.2) 0.9 (SD ±1.2) 0.93
Number of stents 1.1 (SD ±0.4) 1.0 (SD ±0.4) 0.22
IIb/IIIa – tirofiban [%] 16.9 (n = 9) 7.5 (n = 4) 0.019
Table I. Clinical characteristics of patients
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Baseline regional wall motion score index
(WMSI) and regional contrast score index (RCSI)
were calculated at least 48 h after PCI. Optison®
contrast agent was administered via a peripheral
vein. Myocardial contrast echocardiography was
performed using a modality of subsequent data
acquisition of triggered end-systolic images. The
criterion for good perfusion on MCE was defined as
homogeneous enhancement in 50% of wall
thickness in each segment.
Echocardiographic images were digitally stored
in a cine loop format for off-line analysis by 
2 experienced observers. Discrepancies were
resolved by consensus. Baseline fundamental
imaging, including 2 parasternal (long and short
axis) views, were used to evaluate baseline regional
and global wall motion score indexes using the
16-segment model prior to myocardial contrast
echocardiography [8]. For each wall segment,
motion was scored as 1 (normal), 2 (hypokinetic), 
3 (akinetic), or 4 (dyskinetic). Left ventricular
ejection fraction (LVEF) and wall motion score index
(WMSI) were obtained for all echo scans. Wall
motion score index was obtained by dividing the
sum of the segment scores by the number of
segments scored. 
Left ventricular ejection fraction was derived
using the modified bi-plane Simpson’s method,
from orthogonal apical long-axis projections 
(4-chamber view and 2-chamber view). All
measurements were derived in blinded fashion by
2 experienced operators. The 3 mean measu  -
rements of the best visualized cardiac cycles were
calculated for each echo study.
Application of contrast agent
After pre-injection recordings, the ultrasound
contrast agent Optison® was injected intravenously.
This contrast agent consists of perfluorocarbon
filled microbubbles with a median diameter of 
3-4 µm (Amersham, USA). A dose of 1 ml of contrast
agent followed by 10 ml of saline was injected. This
was chosen following the results of pilot studies.
One bolus injection was administered for each
echocardiographic view [9]. At least 5 beats prior to
and 30 beats after the injection were recorded for
each view.
Definitions
Myocardial perfusion of each segment was
assessed using the following grading: poor or no
opacification, partial opacification, adequate
opacification or artefacts. Adequate opacification
was scored when the segment showed
homogeneous opacification in at least one view.
Partial opacification was scored as inadequate
myocardial enhancement in any view relative to
adjacent segments with adequate opacification.
Lack of opacification was scored as low myocardial
enhancement. Artefacts were differentiated from
perfusion defects prior to final analysis. Based on
MCE results, patients were categorized according
to the presence or absence of a myocardial
perfusion defect in at least one segment in the
dysfunctional area. 
The presence of myocardial perfusion was
defined as adequate opacification in that segment.
Areas of no or poor myocardial opacification were
regarded as myocardial perfusion defects. 
RCSI was calculated by dividing the sum of
perfusion assessment of every asynergic segment
by the number of evaluated segments. For each
segment good myocardial perfusion was scored as
1. Segments with partial, poor or no opacification
were scored as 0. Range of RCSI was 0-1 [10]. In
cases of normal perfusion, RCSI was 1.
Primary coronary intervention
In all patients coronary angiography and
intervention were performed within 12 h of the onset
of symptoms. Ninety patients underwent primary
stent implantation. Arterial access was by the right
femoral artery. Selective coronary arteriography was
performed using standard techniques [11]. The infarct-
related artery (IRA) was identified based on coronary
anatomy, regional LV dysfunction and ECG changes. 
The PCI procedure was considered successful
when the residual stenosis was < 30%, in the
absence of dissection. The IRA was analysed both
before and after primary coronary angioplasty to
assess the residual stenosis. Contrast flow through
the epicardial vessel was graded using the standard
TIMI trial flow scale of 0 to 3. All angiograms were
analysed by 2 observers blinded to clinical and
echocardiography results. In the case of
disagreement, a third observer reviewed the film
and discrepancies were resolved by consensus.
Pharmacological treatment in the catheterization
laboratory included intravenous heparin at the
beginning of the procedure. Thirteen patients were
treated with the IIb/IIIa inhibitor (tirofiban) at the
discretion of the PCI operator. 
Statistical analysis
Continuous variables were expressed as mean ±
standard deviation and compared by means of 
2-tailed unpaired t-test (for parametric variables) and
Mann-Whitney U-test (for non-parametric variables).
Discrete variables were expressed as percentages of
the study population and compared by the χ2 test
or Fisher’s exact test. To assess the correlation
between the number of segments with perfusion
defect and clinical, laboratory and echocardiographic
variables, Spearman test was used. Perfusion defects
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assessed by echocardiography were compared in
various groups of patients established according to
tissue perfusion on angiography using the analysis
of variance (ANOVA) with post-hoc Tukey test.
Analysis of EF, EDV and ESV during follow-up was
also performed using ANOVA for repeated measures.
For assessment of predictors of reperfusion
a multivariate analysis was used. A value of p < 0.05
was considered statistically significant. Statistical
analyses were performed with Statistica 6.0 for
Windows (2000).
Results
A total of 100 consecutive patients were
included, of whom all were available for
echocardiographic analysis. There were no
significant differences between groups with respect
to age, sex, heart rate, arterial pressure and
pharmacological treatment as well as mean pain-
to-balloon time (Table I).
Group 1 consisted of 53 patients without
perfusion defect on MCE, while in 47 patients
(Group 2) segments with perfusion disturbances
were found. Mean RCSI in Groups 1 and 2 was 
1 ±0.0 and 0.56 ±0.4, respectively (p = 0.0064). 
From 1600 segments in all enrolled patients we
analysed 717 asynergic segments. Among the 
717 segments assessed by MCE, 168 (22%) revealed
partial or total lack of perfusion. Sixteen segments
had inadequate MCE images due to difficulties with
imaging of the medial and basal segments of the
lateral wall. These 16 segments were not included
in the analysis. Medial and basilar segments of
lateral wall were assessed only in lateral and antero-
lateral infarctions. 
Relationship between myocardial perfusion 
defects assessed by myocardial contrast 
echocardiography and clinical and laboratory
parameters 
In Group 1 the infarct-related artery was the left
anterior descending coronary artery in 16 patients
(30.1%), the right coronary artery in 31 patients
(58.5%), and the circumflex coronary artery in 
6 patients (11.4%). In Group 2 the infarct-related artery
was the left anterior descending coronary artery in
29 (63.0%), the right coronary artery in 12 (26.1%),
and the circumflex coronary artery in 5 (10.9%).
More anterior infarcts were found and
consequently the infarct-related artery was more
often the left anterior descending in patients with
a perfusion defect (Group 2). Out of 53 patients
from Group 1 only 13 had anterior myocardial
infarction, whereas in Group 2 there were 29
anterior myocardial infarctions (p = 0.00014). 
Patients with anterior AMI had significantly more
segments with perfusion defect evaluated with
MCE than patients with inferior myocardial
infarction (p = 0.0001). 
Patients from the group with perfusion defect
had more segments with impaired contractility 
(p = 0.0001) and higher WMSI (p = 0.0009). The
mean number of segments with contractility
disturbances in Group 1 was 5 and in Group 2 was
9. Regional WMSI in Group 1 and Group 2 was 
1.4 and 1.6, respectively (p = 0.0009). 
Group 1 had higher ejection fraction (EF biplane)
than Group 2 (44.7 ±8.2 and 55.9 ±7.4% respectively,
p = 0.000067), lower ESV (66.0 ±6.3 and 52.6 ±7.2 ml
respectively, p= 0.003185) and lower WMSI (1.47 ±0.3
and 1.60 ±0.4 respectively, p = 0.0009) (Table III).
There were no differences between the groups in EDV
(118.3 and 110.5 ml, respectively, p = 0.29). 
In the multivariate analysis, absence of anterior
myocardial infarction (p = 0.0017), high EF on
echocardiography (B = –0.31, p = 0.006) and use of
IIb/IIIa blockers (B = –0.31, p = 0.004) were the only
predictors of reperfusion on MCE.
Only 13 patients from the whole study group
received tirofiban, 16.9% of patients from the group
without perfusion defect and 7.5% from the group
with perfusion defect. The patients treated with
tirofiban had significantly lower RCSI than those
who did not receive tirofiban (p = 0.003). 
Smoking was more frequent in patients with
perfusion defect on MCE but the difference was at
the limit of significance (p = 0.053). In multivariate
analysis smoking (B = 0.2, p = 0.053) and the
highest value of CK-MB activity within 2 days after
admission to the hospital (B = 0.21, p = 0.037) were
predictors of perfusion defect on MCE. Peak CK-MB
correlated well with WMSI (p = 0.037) and with
RCSI in Group 2 (p = 0.037).
During in-hospital stay we did not observe any
serious cardiovascular events, which is not
surprising when one considers the 1-vessel coronary
disease population.
Six-month clinical follow-up 
Ten patients were unavailable for follow-up: 
2 from Group 1 and 8 from Group 2. In Group 1,
LVEF increased significantly from baseline 52.1%
on admission to 55.9% on 6-month follow-up 
(p = 0.026), while in Group 2, it decreased from
45% on admission to 43%. The difference
between the groups in LVEF was statistically
significant (p = 0.0175). Both EDV and ESV were
significantly lower in Group 1 (113.5 and 137.8 ml,
respectively,  p = 0.0106; 59.0 and 82.0 ml
respectively,  p = 0.002882). There was
a statistically significant correlation between the
presence of perfusion defects in the initial
contrast echo and the change in ejection fraction
during the follow-up (ANOVA for repeated
measures, p = 0.0175) (Figure 1).Generally, the patients who had good MCE
results also had, in the majority of cases, long-term
improvement of ventricular function.
Patients from Group 2 had a higher incidence of
death during the 6-month follow-up period. Two
out of 39 patients (5%) died, whereas there were
no deaths in the group with good perfusion on MCE.
Two patients (5%) in Group 2 had non-fatal
myocardial infarction, while there were no patients
who sustained subsequent myocardial infarction in
Group 1. The combined end-point (death and
reinfarction) was significantly lower in patients
without perfusion defect (p = 0.039). 
Discussion
Our study showed that in patients with a first
acute myocardial infarction with single vessel
disease and successfully treated with primary PCI,
perfusion assessed by contrast echocardiography
correlates well with certain clinical and
echocardiographic parameters.
Recent studies have demonstrated that
myocardial perfusion and metabolism are often
abnormal, despite restoration of TIMI 3 flow in the
infarct-related artery [1, 2, 4]. This “no-reflow”
phenomenon is thought to be the result of
microvascular obstruction [12, 13]. This
phenomenon is a marker of more extensive
myocardial tissue damage and has been proven
to be associated with poorer functional recovery,
an increased frequency of heart failure and poor
survival [4, 14]. That is why there is a growing need
to establish a reliable marker of myocardial
perfusion. Several markers of myocardial perfusion
have been proposed. Among these are
electrocardiographic (ST-segment elevation
resolution), echocardiographic (MCE) and
angiographic methods (TIMI myocardial perfusion
grade – TMPG; myocardial blush grade – MBG;
corrected TIMI frame count – CTFC) [15-18]. What
all of them have in common is that they give
information about perfusion and, at the same
time, patients’ prognosis. In the present study
population despite TIMI 3 flow, more than 40% of
patients had some degree of perfusion defect
detected by MCE.
Myocardial contrast echocardiography, actively
studied and compared with many diagnostic tools,
appears to have feasibility and accuracy comparable
with SPECT ([99m] Tc-sestamibi single photon
emission computed tomography) imaging.
Myocardial uptake using SPECT depends largely on
myocardial microvascular volume. Myocardial
contrast echocardiography detects not only
microvascular volume but also blood flow [10, 19].
These differing mechanisms may affect the relative
accuracies of MCE and SPECT for detecting
myocardial viability and perfusion early after AMI.
Myocardial contrast echocardiography was also
compared with SPECT early after first AMI [19].
Contractile reserve was assessed 3 months
following revascularization. The sensitivity and
specificity of MCE and SPECT were 83 and 78% 
(p = ns) and 78 and 45% (p = 0.01), respectively.
MCE was the only multivariate predictor of global
recovery of function and contractile reserve 
(OR = 3.5, p = 0.01). The different physiological
mechanisms employed by MCE and SPECT translate
into different relative accuracies for the detection
of myocardial perfusion and viability. Our findings
showed that the presence of myocardial perfusion
on MCE, from either collateral or antegrade flow,
provided information on the extent of infarction
and was associated with recovery of resting wall
motion.
Our study compared simple-to-determine non-
invasive markers of reperfusion. The principle
findings were that: 1) MCE results also correlated
with recovery of systolic left ventricular function
and clinical outcome at 6-month follow-up, 
2) anterior AMI was associated with a greater
extent of perfusion defect in patients treated with
primary PCI, 3) treatment with a IIb/IIIa inhibitor
was associated with better myocardial tissue
perfusion in patients with AMI.
In our study serious adverse events (2 deaths
and 2 non-fatal myocardial infarctions) occurred
only in the group with perfusion defect on MCE. 
Contrast echocardiography has previously been
validated as the reference technique for evaluation
of myocardial perfusion [1, 19-24]. The most
%
Figure 1. The ejection fraction during the index
hospitalization and after 6-month follow-up in
patients with perfusion defects on contrast
echocardiography (dotted line, squares) or with
proper perfusion (solid line, circles). Data are
presented as average ± 95% confidence interval.
ANOVA for repeated measures revealed statistically
significant interaction between the presence of
perfusion defects on echocardiography and change
in ejection fraction during follow-up (F[1.91] = 5.8554,
p = 0.0175)
ANOVA for repeated measures
F(1.91) = 5.8554, p = 0.01752
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important advantage is that it can be applied in the
setting of acute myocardial infarction. The “no-
reflow” phenomenon is detected by contrast
echocardiography in 16% of patients with TIMI 3 flow.
Contrast echocardiography has been chosen by Agati
et al. [25] as a tool to prove the superiority of primary
PCI over thrombolytic therapy. Kamp et al. [9] carried
out serial myocardial contrast echocardiography in
patients after primary PCI, showing that a significant
reduction in size of the initial perfusion defect
predicts functional recovery after 4 weeks, and these
findings underscore the potential diagnostic value
of the method. In AMI treated with PCI it may have
not only therapeutic implications, but also prognostic
significance, since “no-reflow” is associated with left
ventricular dysfunction at follow-up [26].
We assume that our main division of the study
population into one group with and one group
without perfusion defects assessed by MCE was well
founded and reasonable, as almost all
echocardiographic and clinical outcomes turned out
to be better in the group without perfusion defects
on MCE.
Despite its potential to assess myocardial
perfusion in a non-invasive way, MCE has not
become a routine clinical tool thus far. An important
limitation is that the underlying pathophysiology is
complex. Moreover, appropriate interpretation of
MCE requires experience and training. Furthermore,
sophisticated software is needed to perform the
studies optimally and to acquire accurate data.
As demonstrated in the present as well as in
previous studies, reperfusion markers correlate with
clinical outcome at follow-up.
In conclusion:
1) MCE results correlated with clinical outcome and
recovery of systolic left ventricular function at 
6-month follow-up,
2) anterior AMI was associated with a greater
extent of perfusion defect in patients treated
with primary PCI,
3) treatment with a IIb/IIIa inhibitor was associated
with better myocardial tissue perfusion in
patients with AMI,
4) MCE is an uncomplicated bedside method of
perfusion assessment at a microvascular level in
patients with AMI and gives additional
information about actual infarct size, thus
enabling early evaluation of the success of
primary PCI results.
Study limitations
Regional wall thickening and motion were
evaluated with echocardiography by semi-
quantitative analysis.
It was not possible to evaluate the exact role of
various drugs, in particular ACE inhibitors, which
were given in the majority of cases. 
In our study, treatment with tirofiban was not
randomized. Thirteen patients were treated with
tirofiban at the discretion of the PCI operator. In
those who received tirofiban, anterior myocardial
infarction was prevalent. Nevertheless, patients
treated with this IIb/IIIa inhibitor had fewer
perfusion defects with MCE than those who did not
receive tirofiban. 
The presented results cannot be applied to
patients with complicated myocardial infarction or
multivessel disease, who were excluded from the
study.
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